Probiotics and Intestinal Diseases
نویسندگان
چکیده
منابع مشابه
Probiotics and lung diseases.
Increasing awareness of the role of intestinal commensal bacteria in the development and modulation of the immune system has led to great interest in the therapeutic potential of probiotics and other bacteria-based strategies for a range of immune-related disorders. Studies in animal models have identified strong immunomodulatory effects of many nonpathogenic bacteria and provided evidence that...
متن کاملIntestinal flora, probiotics, and cirrhosis.
Intestinal microflora constitutes a symbiotic ecosystem in permanent equilibrium, composed mainly of anaerobic bacteria. However, such equilibrium may be altered by daily conditions as drug use or pathologies interfering with intestinal physiology, generating an unfavorable environment for the organism. Besides, there are factors which may cause alterations in the intestinal wall, creating the ...
متن کاملProbiotics and respiratory tract diseases.
In a double-blind randomized controlled trial (DBRCT) in 1,000 shift workers [23] the intake of fermented milk drinks containing Lactobacillus casei DN114 001 twice daily reduced the occurrence of CID during the cold season, the time until infections occurred and the duration of fever episodes. During infections the counts of leucocytes, granulocytes and natural killer cells were enhanced. In a...
متن کاملProbiotics and inflammatory bowel diseases.
Enteric microflora profiles vary considerably between active inflammatory bowel diseases (IBD) and healthy conditions. Intestinal microflora may partake in the pathogenesis of IBD by one or some ways: specific pathogenic infection induces abnormal intestinal mucosal inflammation; aberrant microflora components trigger the onset of IBD; abnormal host immune response loses normal immune tolerance...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Nutrition and Metabolism
سال: 2010
ISSN: 1421-9697,0250-6807
DOI: 10.1159/000309094